Here is the latest stock price and chart of NURECA. For more details, see the NURECA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Nov 21, 2024 03:34:00 PM | ||
---|---|---|---|
Price (Rs)273.25 | Open (Rs) 275.00 | High (Rs) 276.45 | Low (Rs) 270.00 |
% Change-1.89 | Volume 1,838 | Value (Rs) 502,234 | 52-Week H/L 468.25 / 240.90 |
Live NSE Quotes | Nov 21, 2024 3:29:17 PM | ||
---|---|---|---|
Price (Rs)274.00 | Open (Rs) 277.50 | High (Rs) 277.50 | Low (Rs) 270.15 |
% Change-1.26 | Volume 6,245 | Value (Rs) 1,705,822 | 52-Week H/L 0.00 / 0.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.89% | 1 Month -7.29% | 3 Months 0.85% | 1 Year -23.62% |
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* -2.80 | P/E Ratio (x) NM | Market Cap (Rs m) 2,732.55 | P/BV (x) 1.43 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
NURECA last traded price was down 1.9% to Rs 273.3 on the BSE. On the NSE, NURECA last traded price was down 1.3% to Rs 274.0. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.1%. And the benchmark S&P BSE SENSEX was at 77,155.8 (down 0.5%).
Over the last 30 days, the NURECA share price is down 9.9%. And over the last one year, NURECA share price is down 22.9%.
The current market capitalisation of NURECA stands at Rs 2,732.55 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of September 2024, company promoters held 63.77% stake in NURECA, with no shares having been pledged. To know more, check out the latest shareholding pattern of NURECA.
The last traded price of NURECA was Rs 273.3 on the BSE, down 1.9% over the previous close. On the NSE, NURECA last traded price was down 1.3% at Rs 274.0.
The current market capitalisation of NURECA stands at Rs 2,733 m. For more information, check out the list of top 100 companies in India in terms of market cap.
NURECA had an EPS of Rs -2.8 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -0.5.
For the financial year 2024, NURECA declared dividend amounting to Rs 0.0 per share. At the current price of Rs 273.3, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.